![Table 1 from The Effect of Low-Dose Nitroglycerin Ointment on Skin Flap Necrosis in Breast Reconstruction after Skin-Sparing or Nipple-Sparing Mastectomy | Semantic Scholar Table 1 from The Effect of Low-Dose Nitroglycerin Ointment on Skin Flap Necrosis in Breast Reconstruction after Skin-Sparing or Nipple-Sparing Mastectomy | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d5e9774779768c3aed8c5ed05c60d0f7327ed1d0/4-Figure2-1.png)
Table 1 from The Effect of Low-Dose Nitroglycerin Ointment on Skin Flap Necrosis in Breast Reconstruction after Skin-Sparing or Nipple-Sparing Mastectomy | Semantic Scholar
![The Use of Topical Nitroglycerin Ointment to Treat Peripheral Tissue Ischemia Secondary to Arterial Line Complications in Neonates | Journal of Perinatology The Use of Topical Nitroglycerin Ointment to Treat Peripheral Tissue Ischemia Secondary to Arterial Line Complications in Neonates | Journal of Perinatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.jp.7210713/MediaObjects/41372_2002_Article_BF7210713_Fig1_HTML.jpg)
The Use of Topical Nitroglycerin Ointment to Treat Peripheral Tissue Ischemia Secondary to Arterial Line Complications in Neonates | Journal of Perinatology
![About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure](https://www.rectiv.com/Assets/Images/howToUse.jpg)
About RECTIV (nitroglycerin) Ointment, a treatment for moderate to severe pain of chronic anal fissure
![Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity | Business Wire Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity | Business Wire](https://mms.businesswire.com/media/20240222076554/en/2041963/22/Nitroglycerin_Ointment.jpg)
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity | Business Wire
![Nitrostat Ointment 30gm, schedule: H, , NITROGLYCERIN, 0.2%W/W, , MARUTI PHARMA, OINTMENT, , Angina - NepalMedishop Nitrostat Ointment 30gm, schedule: H, , NITROGLYCERIN, 0.2%W/W, , MARUTI PHARMA, OINTMENT, , Angina - NepalMedishop](https://nepmed-uat.s3.ap-southeast-1.amazonaws.com/products/600x600/90361/nitrostat_ointment_30gm_1.jpg)